Literature DB >> 33403035

Upregulation of miR-1254 promotes Hepatocellular Carcinoma Cell Proliferation, Migration, and Invasion via Inactivation of the Hippo-YAP signaling pathway by decreasing PAX5.

Xu Lu1, Chao Yang1, Yuanchang Hu1, Jian Xu2, Chengyu Shi1, Jianhua Rao1, Weixin Yu2, Feng Cheng1.   

Abstract

Increasing evidence suggests that microRNAs (miRNAs) affect the progression of hepatocellular carcinoma (HCC). However, the exact function and mechanism of miR-1254 in HCC remains unclear. This study explored the effects of miR-1254 on the biological behavior of HCC cells and determined the underlying mechanism. RT-qPCR was used to detect the expression of miR-1254. Gain- or loss-of-function assays determined if miR-1254 affected the biological function of HCC cells in vitro. Dual luciferase reporter assays confirmed the target gene of miR-1254. Tumor xenografts in mice were used to explore the effects of miR-1254 on tumorigenesis and metastasis of HCC. miR-1254 was upregulated in HCC tissues and cell lines and linked to larger tumor size, aggressive vascular invasion and higher Edmondson grade. Lentiviral-based overexpression and knockdown experiments indicated that miR-1254 promoted proliferation, migration, invasion, and the epithelial-mesenchymal transition of HCC cells. The paired box gene 5 (PAX5) was downregulated in HCC tissues, negatively correlated with miR-1254 expression, and confirmed to be a direct target of miR-1254. Restoration of PAX5 reversed the effects of miR-1254 on the biological behavior of HCC cells. Advanced mechanism studies suggested that PAX5 might mediate miR-1254 by regulating the Hippo signaling pathway. Tumor xenografts in mice confirmed that miR-1254 promoted tumorigenesis and metastasis, and led to poor survival. In conclusion, miR-1254 promoted proliferation, migration, and invasion of HCC cells via decreasing Hippo signaling through targeting PAX5 in vitro and in vivo. This miRNA might be a therapeutic target for HCC. © The author(s).

Entities:  

Keywords:  HCC; Hippo signaling pathway; Metastasis; PAX5; Progression; miR-1254

Year:  2021        PMID: 33403035      PMCID: PMC7778534          DOI: 10.7150/jca.49680

Source DB:  PubMed          Journal:  J Cancer        ISSN: 1837-9664            Impact factor:   4.207


  36 in total

1.  MicroRNA-1254 exerts oncogenic effects by directly targeting RASSF9 in human breast cancer.

Authors:  Bin Li; Peng Chen; Jialin Wang; Linxia Wang; Mingzhi Ren; Ruisan Zhang; Jianjun He
Journal:  Int J Oncol       Date:  2018-08-21       Impact factor: 5.650

2.  Paired box gene 5 is a novel tumor suppressor in hepatocellular carcinoma through interaction with p53 signaling pathway.

Authors:  Weili Liu; Xiaoxing Li; Eagle S H Chu; Minnie Y Y Go; Lixia Xu; Guijun Zhao; Lili Li; Ning Dai; Jianmin Si; Qian Tao; Joseph J Y Sung; Jun Yu
Journal:  Hepatology       Date:  2011-02-11       Impact factor: 17.425

Review 3.  The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy.

Authors:  Peter R Galle; Francesco Tovoli; Friedrich Foerster; Marcus A Wörns; Alessandro Cucchetti; Luigi Bolondi
Journal:  J Hepatol       Date:  2017-03-18       Impact factor: 25.083

4.  miR-302/367/LATS2/YAP pathway is essential for prostate tumor-propagating cells and promotes the development of castration resistance.

Authors:  Y Guo; J Cui; Z Ji; C Cheng; K Zhang; C Zhang; M Chu; Q Zhao; Z Yu; Y Zhang; Y-X Fang; W-Q Gao; H H Zhu
Journal:  Oncogene       Date:  2017-07-24       Impact factor: 9.867

Review 5.  Emerging roles for PAX transcription factors in cancer biology.

Authors:  B W Schäfer
Journal:  Gen Physiol Biophys       Date:  1998-09       Impact factor: 1.512

6.  MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation.

Authors:  Ulf Andersson Ørom; Finn Cilius Nielsen; Anders H Lund
Journal:  Mol Cell       Date:  2008-05-23       Impact factor: 17.970

7.  Decreased expression of miR-1254 is associated with cancer aggressiveness and predicts poor outcome in cervical cancer.

Authors:  J Zhou; X Liu; C-H Wang; D Wang; J-J Du
Journal:  Eur Rev Med Pharmacol Sci       Date:  2018-05       Impact factor: 3.507

8.  miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.

Authors:  Wei Kang; Tingting Huang; Yuhang Zhou; Jinglin Zhang; Raymond W M Lung; Joanna H M Tong; Anthony W H Chan; Bin Zhang; Chi Chun Wong; Feng Wu; Yujuan Dong; Shiyan Wang; Weiqin Yang; Yi Pan; Wing Po Chak; Alvin H K Cheung; Jesse C S Pang; Jun Yu; Alfred S L Cheng; Ka Fai To
Journal:  Cell Death Dis       Date:  2018-01-24       Impact factor: 8.469

Review 9.  New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer.

Authors:  Anushka Dongre; Robert A Weinberg
Journal:  Nat Rev Mol Cell Biol       Date:  2019-02       Impact factor: 94.444

10.  MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma.

Authors:  Lei Guan; Ting Li; Nanping Ai; Wei Wang; Bing He; Yanxia Bai; Zhaocai Yu; Mingyue Li; Shanshan Dong; Qingge Zhu; Xiao Xiao Ding; Shiming Zhang; Ming Li; Guangbo Tang; Xiaochun Xia; Jing Zhao; Song Lin; Shi Yao; Lei Zhang; Geng Chen; Fang-E Liu; Xinyuan Li; Huqin Zhang
Journal:  J Exp Clin Cancer Res       Date:  2019-10-17
View more
  7 in total

Review 1.  The deadly cross-talk between Hippo pathway and epithelial-mesenchymal transition (EMT) in cancer.

Authors:  Ioanna Akrida; Vasiliki Bravou; Helen Papadaki
Journal:  Mol Biol Rep       Date:  2022-05-23       Impact factor: 2.742

2.  Analysis of multi-omics differences in left-side and right-side colon cancer.

Authors:  Yanyi Huang; Jinzhong Duanmu; Yushu Liu; Mengyun Yan; Taiyuan Li; Qunguang Jiang
Journal:  PeerJ       Date:  2021-05-12       Impact factor: 2.984

3.  miRNA-382-5p Suppresses the Expression of Farnesoid X Receptor to Promote Progression of Liver Cancer.

Authors:  Xiaobo Nie; Huiyang Liu; Xiaoyun Wei; Lanqing Li; Linhua Lan; Lili Fan; Han Ma; Lei Liu; Yun Zhou; Ruifang Hou; Wei-Dong Chen
Journal:  Cancer Manag Res       Date:  2021-10-22       Impact factor: 3.989

4.  Upregulating microRNA-373-3p promotes apoptosis and inhibits metastasis of hepatocellular carcinoma cells.

Authors:  Hongbin Li; Nan Wang; Yuntian Xu; Xiao Chang; Jing Ke; Jun Yin
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

Review 5.  Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway.

Authors:  Geofrey Mahiki Mranda; Zhi-Ping Xiang; Jun-Jian Liu; Tian Wei; Yinlu Ding
Journal:  Front Oncol       Date:  2022-08-12       Impact factor: 5.738

Review 6.  MicroRNAs Regulating Hippo-YAP Signaling in Liver Cancer.

Authors:  Na-Hyun Lee; So Jung Kim; Jeongeun Hyun
Journal:  Biomedicines       Date:  2021-03-30

7.  The Effect of RBP4 on microRNA Expression Profiles in Porcine Granulosa Cells.

Authors:  Yun Zhao; Jiahui Rao; Tong Qiu; Chunjin Li; Xu Zhou
Journal:  Animals (Basel)       Date:  2021-05-13       Impact factor: 2.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.